Novo Nordisk Raises 2026 Sales and Profit Outlook
Novo Nordisk now expects 2026 adjusted sales and operating profit to range from a 2% decline to a 2% increase at constant exchange rates, versus prior guidance for declines of as much as 6% for both.
The company now expects 2026 adjusted sales and operating profit to decline by 2% at constant exchange rates in a worst case scenario, or rise by 2% in a best case scenario, having previously guided to a drop of as much as 6% for both."The improved outlook is driven by increased expectations for GL…